Levesque L, Crooke S T
Isis Pharmaceuticals 2292 Faraday Ave., Department of Molecular Pharmacology 2292 Faraday Ave., Carlsbad, California 92008, USA.
J Pharmacol Exp Ther. 1998 Oct;287(1):425-34.
Beta-adrenergic agonists are well known to increase the activity of adenylate cyclase, yielding increases of the intracellular concentration of cAMP. It has been reported that activation of protein kinase C (PKC) by phorbol esters reduces the amplitude of isoproterenol-induced cAMP production in a 3T3-L1 cell line. In this study, we investigated whether PKC-alpha is involved in this process in murine Swiss 3T3 fibroblasts. A 20-mer phosphorothioate oligonucleotide designed to hybridize to the AUG initiation codon of the murine PKC-alpha mRNA, which contains 2'-O-methoxyethyl modifications incorporated into the 5' and 3' segments of the oligonucleotide, was used to assess the putative role of PKC-alpha in the beta-adrenergic receptor regulation. ISIS 14012 reduced PKC-alpha mRNA for over 72 hr after the initial treatment and the reduction was concentration dependent, whereas the mismatch control, ISIS 13818, had no effect. This depletion was found to be selective; ISIS 14012 had no effect on the mRNA expression of PKC-delta and PKC-zeta. ISIS 14012 reduced in a time and concentration-dependent fashion the levels of immunoreactive PKC-alpha protein by over 85% at 72 hr after treatment. Depletion of PKC-alpha inhibited the effect of isoproterenol-induced cAMP production by phorbol dibutyrate (PdBu). This finding is corroborated by the use of a nonspecific inhibitor of PKC, GF-109203x, which also prevented the effect of PdBu. Depletion of PKC-alpha by ISIS 14012 potentiated isoproterenol-induced cAMP production in cells untreated with PdBu. However, neither depletion of PKC-alpha nor PKC activation by a phorbol ester altered beta-adrenergic receptor affinity and density. PKC activation by PdBu did not alter forskolin-induced cAMP levels, but enhanced cAMP production by cholera toxin. PKC-alpha inhibition by ISIS 14012 had no effect on either cholera toxin-induced increases in cAMP or the acute effects of phorbol esters on cholera toxin in induction of cAMP. Thus, PKC-alpha appears to be involved in the regulation of beta-adrenergic receptor coupling to adenylate cyclase, possibly by phosphorylating the Gs protein, but other PKC isotypes must be involved in the effects observed when cells are treated with cholera toxin.
众所周知,β-肾上腺素能激动剂可增加腺苷酸环化酶的活性,使细胞内cAMP浓度升高。据报道,佛波酯激活蛋白激酶C(PKC)可降低异丙肾上腺素诱导的3T3-L1细胞系中cAMP的产生幅度。在本研究中,我们调查了PKC-α是否参与小鼠瑞士3T3成纤维细胞的这一过程。一种20聚体硫代磷酸酯寡核苷酸,设计用于与小鼠PKC-α mRNA的AUG起始密码子杂交,该寡核苷酸的5'和3'段含有2'-O-甲氧基乙基修饰,用于评估PKC-α在β-肾上腺素能受体调节中的假定作用。ISIS 14012在初始处理后72小时以上降低了PKC-α mRNA,且这种降低呈浓度依赖性,而错配对照ISIS 13818则无作用。发现这种耗竭具有选择性;ISIS 14012对PKC-δ和PKC-ζ的mRNA表达无影响。ISIS 14012在处理后72小时以时间和浓度依赖性方式将免疫反应性PKC-α蛋白水平降低了85%以上。PKC-α的耗竭抑制了佛波二丁酸酯(PdBu)对异丙肾上腺素诱导的cAMP产生的影响。使用PKC的非特异性抑制剂GF-109203x也证实了这一发现,它也阻止了PdBu的作用。ISIS 14012使PKC-α耗竭增强了未用PdBu处理的细胞中异丙肾上腺素诱导的cAMP产生。然而,PKC-α的耗竭或佛波酯对PKC的激活均未改变β-肾上腺素能受体的亲和力和密度。PdBu对PKC的激活未改变福斯高林诱导的cAMP水平,但增强了霍乱毒素诱导的cAMP产生。ISIS 14012对PKC-α的抑制对霍乱毒素诱导的cAMP增加或佛波酯对霍乱毒素诱导cAMP的急性作用均无影响。因此,PKC-α似乎参与了β-肾上腺素能受体与腺苷酸环化酶偶联的调节,可能是通过磷酸化Gs蛋白,但在细胞用霍乱毒素处理时观察到的其他效应肯定涉及其他PKC同工型。